| 14 October, 2024 | Review of current guidelines on palliative sedation |
| 21 October, 2024 | Review of current recommendations on management of diabetes mellitus at end of life |
| 28 October, 2024 | Review of evidence for managing pruritus in patients receiving palliative care |
| 4 November, 2024 | Review of evidence on blood and blood component transfusion at end of life |
| 11 November, 2024 | Review of evidence on serious-health related suffering internationally and in India |
| 18 November, 2024 | Review of guidelines and evidence on use of octreotide in a palliative care setting |
| 25 November, 2024 | Evidence-based approaches for deprescribing in patients with advanced cancer receiving palliative care |
| 2 December, 2024 | Evidence-based guidelines on prevention and management of pressure sores |
| 9 December, 2024 | Evidence for various pharmacological strategies used in management of breakthrough cancer pain |
| 16 December, 2024 | Guidelines and evidence for treating hypercalcemia of malignancy in adults |
| 23 December, 2024 | Current recommendations, evidence and guidelines on management of chemotherapy induced peripheral neuropathy |
| 30 December, 2024 | Evidence of early integration of palliative care in oncological illnesses based on findings of systematic reviews |
| 6 January, 2025 | Evidence, guidelines and recommendations on the role of Direct oral anticoagulants (DOAC) in Cancer thrombosis |
| 13 January, 2025 | Evidence on pharmacogenomics of Opioid analgesics and its clinical implications |
| 20 January, 2025 | Evidence and recommendations regarding assessing suicide risk in a patient receiving palliative care |
| 27 January, 2025 | Review of evidence on the role of palliative care in the setting of cardiac transplantation |
10 February, 2025
(3 Feb break after IAPCON) | Current guidelines and evidence on Palliative Oxygen Therapy |
| 17 February, 2025 | Review of current evidence regarding the use of opioids for managing breathlessness |
